Please note that trial statuses change frequently, call us for the most up-to-date information about enrolling in a clinical trial.
The Jordan Research and Education Institute (REDI)
2450 Ashby Avenue
Berkeley, CA 94705
(510) 486-8371 fax
Breast Cancer Clinical Trial
The purpose of this study is to compare the efficacy of a single dose of SPI-2012 with pegfilgrastim (Neulasta [NDC 55513-190-01] manufactured by Amgen) in patients with early-stage breast cancer receiving docetaxel and cyclophosphamide (TC), as measured by the Duration of Severe Neutropenia (DSN) in Cycle 1.
Sutter Health Research Institute Resources
Jordan Research and Education Institute News
Joanna Cooper, M.D., and her colleagues are involved in a well-conceived, comprehensive program for multiple sclerosis (MS) care and clinical research, with a dozen projects currently under way, from single-center to international studies. Her work ranges from trials for innovative medications and combination therapies to a new tool for assessing an MS patient’s quality of life and symptom relief therapies. Collectively, the studies are broad in scope, addressing different types and various stages of the disease.
Anesthesiologist John Donovan, M.D., is participating in a pilot triple-masked, placebo-controlled study to test the effect of continuous femoral nerve blocks on readiness for hospital discharge following total knee replacement surgery.
Ward Hagar, M.D., is currently working on a phase III double-blind, randomized, placebo-controlled study sponsored by the National Institutes of Health to determine whether nitric oxide inhalation is effective in the acute treatment of sickle-cell pain.